Pipeline Progresses at Shire

Pipeline Progresses at Shire – Analyst Blog

By: Stock Market News & Stocks to Watch from StraightStocks

Posted on February 12, 2013 at 13:03 PM EST

Shire recently announced that the company has initiated a phase III study to evaluate the efficacy and safety of Dermagraft for the treatment of non-healing wounds in patients suffering from epidermolysis bullosa (EB).

Related Stocks:

Bayer Aktiengesellschaft American Depositary Shares Eli Lilly & Co.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates